Cumberland Pharms Drug Patent Portfolio
Cumberland Pharms owns 2 orange book drugs protected by 17 US patents Given below is the list of Cumberland Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8952065 | Acetylcysteine composition and uses thereof | 10 Feb, 2035 | Active |
| US8722738 | Acetycysteine compositions and methods of use thereof | 06 Apr, 2032 | Active |
| US11806400 | Injectable ibuprofen formulation | 16 Mar, 2032 | Active |
| US9072661 | Injectable ibuprofen formulation | 16 Mar, 2032 | Active |
| US9072710 | Injectable ibuprofen formulation | 16 Mar, 2032 | Active |
| US9327028 | Acetylcysteine compositions and methods of use thereof | 21 Jul, 2031 | Active |
| US9012508 | Administration of intravenous ibuprofen | 14 Sep, 2030 | Active |
| US8735452 | Treating patients with intravenous ibuprofen | 30 Sep, 2029 | Active |
| US8871810 | Treating critically ill patients with intravenous ibuprofen | 30 Sep, 2029 | Active |
| US9114068 | Treating patients with intravenous ibuprofen | 30 Sep, 2029 | Active |
| US9138404 | Treating critically ill patients with intravenous ibuprofen | 30 Sep, 2029 | Active |
| US9295639 | Treating critically ill patients with intravenous ibuprofen | 30 Sep, 2029 | Active |
| US9649284 | Treating critically ill patients with intravenous ibuprofen | 30 Sep, 2029 | Active |
| US8148356 | Acetylcysteine composition and uses therefor | 21 May, 2026 | Active |
| US8399445 | Acetylcysteine composition and uses thereof | 24 Aug, 2025 | Active |
| US8653061 | Acetylcysteine composition and uses thereof | 24 Aug, 2025 | Active |
| US6727286 | Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid | 27 Nov, 2021 | Expired |
Latest Legal Activities on Cumberland Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Cumberland Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Email Notification
Critical
| 07 Nov, 2023 | US11806400 |
|
Recordation of Patent Grant Mailed
Critical
| 07 Nov, 2023 | US11806400 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 07 Nov, 2023 | US11806400 |
| Recordation of Patent eGrant | 07 Nov, 2023 | US11806400 |
| Patent eGrant Notification | 07 Nov, 2023 | US11806400 |
| Mail Patent eGrant Notification | 07 Nov, 2023 | US11806400 |
|
Email Notification
Critical
| 19 Oct, 2023 | US11806400 |
|
Issue Notification Mailed
Critical
| 18 Oct, 2023 | US11806400 |
| Dispatch to FDC | 06 Oct, 2023 | US11806400 |
|
Application Is Considered Ready for Issue
Critical
| 06 Oct, 2023 | US11806400 |
|
Issue Fee Payment Received
Critical
| 03 Oct, 2023 | US11806400 |
|
Issue Fee Payment Verified
Critical
| 03 Oct, 2023 | US11806400 |
|
Mail Notice of Allowance
Critical
| 27 Sep, 2023 | US11806400 |
|
Notice of Allowance Data Verification Completed
Critical
| 25 Sep, 2023 | US11806400 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 20 Sep, 2023 | US8148356 (Litigated) |
Cumberland Pharms's Drug Patent Litigations
Cumberland Pharms's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Dec 04, 2012, against patent number US9295639. The petitioner , challenged the validity of this patent, with Leo PAVLIV et al as the respondent. Click below to track the latest information on how companies are challenging Cumberland Pharms's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US9295639 | December, 2012 |
Decision
(17 Sep, 2015)
| Leo PAVLIV et al | |
Cumberland Pharms's Family Patents
Cumberland Pharms Drug List
Given below is the complete list of Cumberland Pharms's drugs and the patents protecting them.
1. Acetadote
Acetadote is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8952065 | Acetylcysteine composition and uses thereof |
10 Feb, 2035
(10 years from now)
| Active |
| US8722738 | Acetycysteine compositions and methods of use thereof |
06 Apr, 2032
(7 years from now)
| Active |
| US9327028 | Acetylcysteine compositions and methods of use thereof |
21 Jul, 2031
(6 years from now)
| Active |
| US8148356 | Acetylcysteine composition and uses therefor |
21 May, 2026
(1 year, 6 months from now)
| Active |
| US8399445 | Acetylcysteine composition and uses thereof |
24 Aug, 2025
(9 months from now)
| Active |
| US8653061 | Acetylcysteine composition and uses thereof |
24 Aug, 2025
(9 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Acetadote's drug page
2. Caldolor
Caldolor is protected by 11 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11806400 | Injectable ibuprofen formulation |
16 Mar, 2032
(7 years from now)
| Active |
| US9072661 | Injectable ibuprofen formulation |
16 Mar, 2032
(7 years from now)
| Active |
| US9072710 | Injectable ibuprofen formulation |
16 Mar, 2032
(7 years from now)
| Active |
| US9012508 | Administration of intravenous ibuprofen |
14 Sep, 2030
(5 years from now)
| Active |
| US8735452 | Treating patients with intravenous ibuprofen |
30 Sep, 2029
(4 years from now)
| Active |
| US8871810 | Treating critically ill patients with intravenous ibuprofen |
30 Sep, 2029
(4 years from now)
| Active |
| US9114068 | Treating patients with intravenous ibuprofen |
30 Sep, 2029
(4 years from now)
| Active |
| US9138404 | Treating critically ill patients with intravenous ibuprofen |
30 Sep, 2029
(4 years from now)
| Active |
| US9295639 | Treating critically ill patients with intravenous ibuprofen |
30 Sep, 2029
(4 years from now)
| Active |
| US9649284 | Treating critically ill patients with intravenous ibuprofen |
30 Sep, 2029
(4 years from now)
| Active |
| US6727286 | Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid |
27 Nov, 2021
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Caldolor's drug page